We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves First Generic Celebrex, Mylan Appeals Teva’s Exclusivity Ruling
FDA Approves First Generic Celebrex, Mylan Appeals Teva’s Exclusivity Ruling
Generic drug giant Teva received FDA clearance May 30 to market exclusive versions of Pfizer’s blockbuster arthritis pain drug Celebrex (celecoxib) in the 100 mg, 200 mg and 400 mg capsule forms.